Page 99 - Remedial Andrology
P. 99

increases endothelial nitric oxide synthase (eNOS) and  α-smooth muscle actin, given their role in the
            pathogenesis  of  PD  [1083].  Only  one  clinical  study  assessed  the  efficacy  of  VED  therapy  in  mechanically
            straightening the penile curvature of PD as monotherapy and further investigation is needed [1084].

            8.2.3.1.4  Multimodal treatment
            There are some data suggesting that a combination of different oral drugs can be used for treatment of the
            acute phase of PD. However, there does not seem to be a consensus on which drugs to combine or the
            optimum drug dosage; nor has there been a comparison of different drug combinations.
                     A long-term study assessing the role of multimodal medical therapy (injectable verapamil associated
            with antioxidants and local diclofenac) demonstrated that it is efficacious to treat PD patients. The authors
            concluded that combination therapy reduced pain more effectively than verapamil alone, making this specific
            combination treatment more effective compared to monotherapy [1083]. Furthermore, combination protocols
            including injectable therapies, such as CCH, have been studied in controlled trials. The addition of adjunctive
            PTT and VED has been described; however, limited data are available regarding its use [1085].

            Penile traction therapy has been evaluated as an adjunct therapy to intralesional injections with interferon,
            verapamil, or CCH  [1030, 1086, 1087]. These studies have failed to demonstrate significant improvements
            in penile length or curvature, with the exception of one subset analysis identifying a 0.4 cm length increase
            among men using the devices for > 3 hours/day [1087]. A meta-analysis demonstrated that men who used
            PTT as an adjunct to surgery or injection therapy for PD had, on average, an increase in stretched penile length
            (SPL) of 1 cm compared to men who did not use adjunctive PTT. There was no significant change in curvature
            between the two groups [1088].
                     Data available on the combined treatment of CCH and the use of VED between injection intervals
            have  shown significant  mean  improvements in  curvature (-17˚) and  penile length (+0.4  cm)  after  treatment.
            However, it is not possible to determine the isolated effect of VED because of a lack of control groups [1047,
            1088].
                     Recent data have suggested that combination of PDE5I (sildenafil 25 mg twice daily) after CCH
            treatment (shortened protocol combined with VED) is superior to CCH alone for improving penile curvature and
            erectile function. Further studies are necessary to externally validate those findings.

            8.2.3.1.5  Summary of evidence for conservative treatment of Peyronie’s disease

             Summary of evidence                                                            LE
             Conservative treatment for PD is primarily aimed at treating patients in the early stage of the disease in  3c
             order to relieve symptoms and prevent progression.
             There is no convincing evidence supporting oral treatment with acetyl esters of carnitine, vitamin E,   3c
             potassium para-aminobenzoate (potaba) and pentoxifylline.
             Due to adverse effects, treatment with oral tamoxifen is no longer recommended.  3c
             Nonsteroidal anti-inflammatory drugs can be used to treat pain in the acute phase.  5
             Intralesional treatment with calcium channel antagonists: verapamil and nicardipine are no longer   1b
             recommended due to contradictory results.
             Intralesional treatment with collagenase of clostridium histolyticum showed significant decreases in   1b
             penile curvature, plaque diameter
             Intralesional treatment with interferon may improve penile curvature, plaque size and density, and pain. 2b
             Intralesional treatment with steroids are no longer recommended due to adverse effects, including   3c
             tissue atrophy, thinning of the skin and immunosuppression.
             No robust evidence is available to support treatment with intralesional hyaluronic acid or botulinum   3c
             toxin.
             There is no evidence that topical treatments applied to the penile shaft result in adequate levels of the  3c
             active compound within the tunica albuginea.
             The use of iontophoresis is not recommended due to the absence of efficacy data.  3c
             Extracorporeal shockwave treatment may be offered to treat penile pain, but it does not improve   2b
             penile curvature and plaque size.
             Treatment with penile traction therapy alone or in combination with injectable therapy as part of a   3c
             multimodal approach may reduce penile curvature and increase penile length, although studies have
             limitations.








            98                                                SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021
   94   95   96   97   98   99   100   101   102   103   104